Showing results (1891-1900 of 2,187) with videos related to
Sort By:
Pageof 219
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2016
The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 InfectionJeffrey M Jacobson, Lu Zheng, Cara C Wilson, et al.Frontiers in Cardiovascular Medicine|December 12, 2022
Neurocognitive function in patients with atrial fibrillation undergoing pulmonary vein isolationLeon Zwimpfer, Stefanie Aeschbacher, Philipp Krisai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2023
Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 InsertionsZofia Piotrowska, Daniel Shao-Weng Tan, Egbert F Smit, et al.Journal of Medicinal Chemistry|May 13, 2021
Design, Synthesis, and Evaluation of WD-Repeat-Containing Protein 5 (WDR5) DegradersAnja Dölle, Bikash Adhikari, Andreas Krämer, et al.Journal of Psychiatry & Neuroscience : JPN|May 17, 2019
Time heals all wounds? A 2-year longitudinal diffusion tensor imaging study in major depressive disorderJonathan Repple, Dario Zaremba, Susanne Meinert, et al.Translational Psychiatry|October 2, 2024
Associations between antagonistic SNPs for neuropsychiatric disorders and human brain structureLydia M Federmann, Friederike S David, Christiane Jockwitz, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 9, 2026
Elevated Polyreactive Immunoglobulin G in Immune-Mediated Liver Injuries With the Need for Immunosuppressive TherapyTheresa Kirchner, George N Dalekos, Kalliopi Zachou, et al.Journal for Immunotherapy of Cancer|October 31, 2022
First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumorsElizabeth J Davis, Juan Martin-Liberal, Rebecca Kristeleit, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancerB D Curti, A C Ochoa, G C Powers, et al.Journal of Affective Disorders|June 26, 2022
Interaction of recent stressful life events and childhood abuse on orbitofrontal grey matter volume in adults with depressionKai G Ringwald, Julia-Katharina Pfarr, Simon Schmitt, et al.Pageof 219